Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, Zizzi F, Frizziero L
Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Rheumatology (Oxford). 2001 Feb;40(2):158-69. doi: 10.1093/rheumatology/40.2.158.
The study was part of a randomized open-label clinical trial designed to evaluate the effects of intra-articular injections of hyaluronan (Hyalgan) (HY) in osteoarthritis (OA) of the human knee. Data were compared with those obtained after treatment with methylprednisolone acetate (Depomedrol) (MP).
Synovial membranes from patients with OA of the knee, primary or secondary to a traumatic event and classified according to the American College of Rheumatology criteria, were examined by arthroscopy and by light and electron microscopy before and 6 months after local injection of HY (2 ml of 500-730 000 MW hyaluronan, 10 mg/ml in saline, one injection per week for 5 weeks) or MP (1 ml of methylprednisolone acetate, 40 mg/ml, one injection per week for 3 weeks).
Arthroscopy revealed a significant decrease in inflammatory score after both treatments. Histology showed that HY treatment was effective (P< or =0.05) in reducing the number and aggregation of lining synoviocytes, as well as the number and calibre of the vessels. MP treatment significantly reduced the number of mast cells in primary OA. Both treatments tended to decrease the number of hypertrophic and to increase the number of fibroblast-like lining cells, to decrease the numbers of macrophages, lymphocytes, mast cells and adipocytes, and to decrease oedema, especially in primary OA, and to increase the number of fibroblasts and the amount of collagen. These phenomena were evident throughout the thickness of the synovial tissue.
At least in the medium term, both HY and MP modified a number of structural variables of the synovial membrane of the osteoarthritic human knee towards the appearance of that of normal synovium. The effect was more evident in primary OA than in OA secondary to a traumatic event. This is the first evidence that local hyaluronan injections modify the structural organization of the human knee synovium in OA.
本研究是一项随机开放标签临床试验的一部分,旨在评估关节内注射透明质酸(海乐妙)(HY)对人膝关节骨关节炎(OA)的影响。将数据与醋酸甲泼尼龙(得宝松)(MP)治疗后获得的数据进行比较。
根据美国风湿病学会标准分类的原发性或继发于创伤事件的膝关节OA患者的滑膜,在局部注射HY(2ml 500 - 730000MW透明质酸,盐水中10mg/ml,每周注射一次,共5周)或MP(1ml醋酸甲泼尼龙,40mg/ml,每周注射一次,共3周)之前和之后6个月,通过关节镜检查以及光镜和电镜进行检查。
关节镜检查显示两种治疗后炎症评分均显著降低。组织学表明,HY治疗在减少衬里滑膜细胞的数量和聚集以及血管的数量和管径方面有效(P≤0.05)。MP治疗显著减少了原发性OA中肥大细胞的数量。两种治疗都倾向于减少肥大细胞数量并增加成纤维细胞样衬里细胞数量,减少巨噬细胞、淋巴细胞、肥大细胞和脂肪细胞数量,减少水肿,尤其是在原发性OA中,增加成纤维细胞数量和胶原蛋白量。这些现象在整个滑膜组织厚度中都很明显。
至少在中期,HY和MP都使骨关节炎人膝关节滑膜的一些结构变量朝着正常滑膜的外观改变。这种效果在原发性OA中比在继发于创伤事件的OA中更明显。这是局部注射透明质酸改变OA中人类膝关节滑膜结构组织的首个证据。